Your browser doesn't support javascript.
loading
Early phase II study of S-1, a new oral fluoropyrimidine, for advanced non-small-cell lung cancer.
Furuse, K; Kawahara, M; Hasegawa, K; Kudoh, S; Takada, M; Sugiura, T; Ichinose, Y; Fukuoka, M; Ohashi, Y; Niitani, H.
Affiliation
  • Furuse K; Division of Respiratory Diseases, Health Insurance Union Osaka Central Hospital, 3-3-17 Niwashirodai, Sakai, Osaka 590-0133, Japan. ha7k-frs@asahi-net.or.jp
Int J Clin Oncol ; 6(5): 236-41, 2001 Oct.
Article in En | MEDLINE | ID: mdl-11723745
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Oxonic Acid / Pyridines / Tegafur / Carcinoma, Non-Small-Cell Lung / Lung Neoplasms / Antimetabolites, Antineoplastic Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Int J Clin Oncol Journal subject: NEOPLASIAS Year: 2001 Document type: Article Affiliation country: Japón Country of publication: Japón
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Oxonic Acid / Pyridines / Tegafur / Carcinoma, Non-Small-Cell Lung / Lung Neoplasms / Antimetabolites, Antineoplastic Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Int J Clin Oncol Journal subject: NEOPLASIAS Year: 2001 Document type: Article Affiliation country: Japón Country of publication: Japón